...
首页> 外文期刊>Journal of plastic, reconstructive & aesthetic surgery: JPRAS >VEGF gene therapy for the survival of transplanted fat tissue in nude mice.
【24h】

VEGF gene therapy for the survival of transplanted fat tissue in nude mice.

机译:VEGF基因疗法可帮助裸鼠移植脂肪组织存活。

获取原文
获取原文并翻译 | 示例
           

摘要

The objective of this study was to determine the effects of adenovirus-mediated vascular endothelial growth factor (Ad-VEGF) on the angiogenesis and survival of free-fat tissue transplantation in nude mice. Thirty 6-week-old CD-1 nude male mice were injected with 1ml fat tissue (harvested by suction-assisted lipectomy from the breast of humans) in the subcutaneous of scalp and were randomised into three groups of 10 animals each. Group 1 was the study group, in which Ad-VEGF was mixed with transplanted fat tissue and injected into mice. In group 2, adenovirus-mediated green fluorescent protein (Ad-GFP) gene was mixed with transplanted fat tissue and injected into the mice. In group 3, normal saline alone was used. Both group 2 and group 3 are control groups. The animals were euthanised 15 weeks after the procedure. The fat survival weight and volume of the study group were significantly greater than those of two control groups (p<0.05). Light microscopical examination of haematoxylin and eosin-stained slides of the dissected fat 15 weeks after injection was performed in group 1 and group 2. Less cyst formation and fibrosis, indicating improved quality of the injected fat, can be obtained by the addition of Ad-VEGF. Vascular density was evaluated at the microvascular level through the use of light microscopic sections of the central part of the fat tissue at 15 weeks after injection by von Willebrand factor staining. Histological evaluation showed that capillary density increased markedly in the study group mice. Mice of the study group disclosed significantly higher VEGF protein levels detected by ELISA assay of plasma samples obtained from the mice after the fat injection (day 1, 4, 7 and 28; p<0.01) at each time point than the mice of the two control groups. The findings reported in this study indicate that the VEGF gene therapy can enhance the survival and the quality of grafted fat tissue, which may be due to induction of angiogenesis.
机译:这项研究的目的是确定腺病毒介导的血管内皮生长因子(Ad-VEGF)对裸鼠游离脂肪组织移植的血管生成和存活的影响。在30只6周大的CD-1裸鼠中,在头皮下注射1ml脂肪组织(通过抽吸辅助脂肪切除术从人的乳房中收集),并随机分为三组,每组10只动物。第一组是研究组,其中将Ad-VEGF与移植的脂肪组织混合并注射到小鼠中。在第2组中,将腺病毒介导的绿色荧光蛋白(Ad-GFP)基因与移植的脂肪组织混合并注入小鼠体内。在第3组中,仅使用生理盐水。第2组和第3组均为对照组。手术后15周,对动物实施安乐死。研究组的脂肪存活重量和体积显着大于两个对照组(p <0.05)。在第1组和第2组中注射15周后,对经解剖的脂肪的苏木精和曙红染色的载玻片进行光学显微镜检查,通过添加Ad-可减少囊肿的形成和纤维化,表明注射脂肪的质量得到改善。 VEGF。在注射后15周,通过von Willebrand因子染色,通过使用脂肪组织中央部分的光学显微切片在微血管水平上评估血管密度。组织学评估表明,研究组小鼠的毛细血管密度显着增加。研究组的小鼠显示,在每个时间点通过脂肪注射后(第1、4、7和28天; p <0.01)从小鼠获得的血浆样品的ELISA分析检测到的VEGF蛋白水平明显高于两只小鼠对照组。这项研究报告的发现表明,VEGF基因疗法可以提高移植脂肪组织的存活率和质量,这可能是由于诱导血管生成所致。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号